🇺🇸 FDA
Patent

US 7635486

Recombinant lipidated PsaA protein, methods of preparation and use

granted A61KA61K39/00A61P

Quick answer

US patent 7635486 (Recombinant lipidated PsaA protein, methods of preparation and use) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Dec 22 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 17 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K39/00, A61P, A61P31/04